Cases
Representative Matters: Represented Certified Collectibles Group, a leading global provider of authentication, grading
conservation services, in its sale to funds managed by private equity firm Blackstone (NYSE: BX)'s Tactical Opportunities business, which valued the company at more than $500 million.
Represented a leading public relations
strategic communications consulting firm focused on the healthcare industry in its $21.5 million sale to a global private equity-backed marketing
communications company.
Represented Wockhardt USA, LLC,
its US affiliated companies, as US counsel, in connection with a $250 million international secured credit facility provided by certain Indian banks to Wockhardt Ltd., an Indian company
parent of Wockhardt USA, LLC.
Represented New Hampshire-based Unitil Corporation (NYSE: UTL) in its sale of $30 million aggregate principal amount of 3.70% senior notes to several well-known insurance companies.
Represented Balchem Corporation (NASDAQ:BCPC) in its acquisition of Performance Chemicals & Ingredients Company (d/b/a SensoryEffects), a privately held supplier of customized food
beverage ingredient systems, for a purchase price of $567 million in cash.
Represented SchoolChapters, Inc. (an educational solutions provider dedicated to st
ards-based education quality management, accreditation services
community-based resources for educators
learners) in its sale to Houghton Mifflin Harcourt Publishing Company (a global learning company with the mission of changing people's lives by fostering passionate, curious learners).
Represented Balchem Corporation in a $450 million syndicated credit facility led by Bank of America. (Nasdaq: BCPC)
Represented Multimodal Technologies, Inc. in the sale of 100 percent of its outst
ing equity securities in a reverse triangular merger to Miami Acquisition Corp., a wholly owned subsidiary of Medquist Holdings, Inc. (NASDAQ:MEDH), for an aggregate purchase price of approximately $130 million, including approximately $50 million in cash at closing, approximately $50 million in Medquist common stock at closing,
approximately $30 million of deferred payments payable in three annual installments.
Represented venture capital
private equity firms in their investments in emerging businesses in various industries.
Represented technology-related development stage companies
their founders in venture capital financing transactions.
Represented an agency of the Ministry of Production of the Russian Federation in an exclusive licensing
marketing arrangement involving rocket
space technology with a major U.S. space contractor.
Represented a publicly held biotechnology company in its development stage financing, initial public offering, subsequent private placement of equity securities, acquisition of a subsidiary manufacturing company, various domestic
international licensing agreements,
SEC reporting
securities law compliance.
Represented an American Stock Exchange manufacturing company in acquisitions, major financings, supply
manufacturing agreements, SEC reporting
securities law compliance, development
implementation of a corporate legal compliance program,
other day-to-day corporate
business matters.
Represented a Japanese distributor of computer software
components
its U.S. subsidiary in a worldwide licensing
distribution agreement.
Represented a software company in its strategic investment in a development stage company with newly developed technology complementary to its existing proprietary products.
Represented the stockholder group (including venture capital investors
senior management) of a publisher of a magazine having a national circulation in the sale of all of the capital stock of the company to a Fortune 500 company.
Represented communications companies in sales of radio stations.
Represented numerous principals of closely held businesses in buy-sell agreements, voting agreements, ownership transition agreements
other shareholders agreements of many types.
Represented a Mexican company in its acquisition of the assets
business of a Mexican manufacturing subsidiary of a publicly traded United States manufacturer
distributor of electrolytic capacitors.
Represented an early stage venture funded company focused on career counseling
internet job recruitment in four rounds of venture financing, several significant strategic partnering agreements,
three strategic acquisitions, including the acquisition of a software company selling complementary software products
tools in a tax-free reverse triangular merger transaction
the acquisitions of substantially all of the assets
business of two competing internet job recruiting companies.
Represented a leading publisher of health information in the fields of alternative
integrative medicine in four rounds of venture financing, several significant strategic partnering agreements, the acquisition of the assets
business of a company in a complementary business,
its subsequent sale to a publicly traded publisher of consumer health information in a tax-free, stock-for-stock, reverse triangular merger transaction.
Represented a cardiac telemedicine
emergency medical services company in its seed round of financing, several strategic partnering agreements, a strategic financing from a publicly traded ambulance
emergency services company
its subsequent sale to an unrelated publicly traded medical services company in a tax-free, reverse triangular merger transaction.
Represented a developer
manufacturer of hydrogen generators
regenerative hydrogen fuel cell systems in three rounds of venture financing, a significant product development
distribution agreement, several sales representative
distribution agreements
other day to day corporate
business matters.
Represented a software company in two rounds of venture capital financing, significant licensing
distribution agreements, the development
refinement of its st
ard form of client licensing agreement
other corporate
business matters.
